Miami, FL, and Basking Ridge, NJ , March 23, 2021 (GLOBE NEWSWIRE) -- The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma LLC, a clinical research and development company, ...
BASKING RIDGE, NJ, & HOLMES CHAPEL, UK, May 7, 2024 - DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized ...
DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable ...
Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants 1 By using Honeywell Solstice ® Air HFO-1234ze technology, a low global warming ...
Marking a significant milestone, DevPro signed a Memorandum of Understanding (MoU) with Alliance Finance Company (PLC) to promote innovative financing for Inclusive Economic Development. The MoU was ...
DevPro Biopharma, Bespak complete early feasibility studies for new groundbreaking albuterol inhaler
DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback